Renin-Angiotensin System


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

Renin-Angiotensin System

 

the enzyme system that forms and destroys the hormone hypertensin. It participates in the regulation of the level of arterial pressure, in the functioning of the kidneys, and in the water-salt metabolism of the body.

Renin is a proteolytic enzyme that acts on the angiotensinogen, or hypertensinogen, of the plasma and lymph to form a decapeptide—angiotensin I. The enzyme contained in the lungs and kidneys acts on angiotensin I and splits off its terminal dipeptide. Angiotensin I is then converted to active angiotensin II, also known as hypertensin or angiotonin. Angiotensin II constricts the blood vessels and stimulates the secretion of other hormones that influence vascular tone and the water-salt metabolism; these hormones include catecholamines, aldosterone, vasopressin, and prostaglandins. Angiotensin II also stimulates the contraction of the uterus.

Human arterial blood contains an average of 2.5 × 10-6 mg of hypertensin per 100 milliliters of plasma. In venous blood the hypertensin concentration is much less because in the tissues it is bonded to receptors and destroyed by enzymes called angio-tensinases. The secretion and activity of renin, and consequently, also the concentration of hypertensin in the blood plasma, increase when the adrenal medulla or sympathetic nerves are excited, when there is a depletion of Na in the body or loss of blood, when blood circulation in the kidneys is disrupted, and during pregnancy. Excess Na in the body suppresses the activity of the renin-angiotensin system.

Activation of the renin-angiotensin system is one of the important factors in the development of both hypertonia, especially malignant hypertonia caused by kidney disease, and edemas, which occur with kidney disease and cardiac insufficiency. In cases of hypertonia caused by a tumor of the adrenal cortex, the activity of the renin-angiotensin system is low. The activity of renin and the concentration of hypertensin in the blood are determined by a diagnostic test performed on an individual exhibiting hypertonicity.

REFERENCES

Fiziologiia pochki. Leningrad, 1972. Chapter 15.
Kidney Hormones. Edited by J. W. Fisher. London-New York, 1971.

IU. A. SEREBROVSKAIA

References in periodicals archive ?
The renin-angiotensin system plays an important role in many types of inflammatory and cardiovascular diseases.
Despite numerous studies, researchers have only closed down on one possible pathway-the renin-angiotensin system (RAS), which regulates blood pressure and fluid retention.
This review of the past five years of research in the endocrinology of hypertension includes articles on new developments in the renin-angiotensin system, the sympatho-adrenal system, metabolic disorders, endothelial hormones and autocoids, and other hormonal systems affected by hypertension.
For the last 20 years, the most widely used method for assessment of the renin-angiotensin system has been the plasma renin activity assay (1).
Current standard of care for CKD is treatment with blood pressure lowering agents that affect the renin-angiotensin system, including Angiotensin Converting Enzyme inhibitors (ACEi) and Angiotensin Receptor Blockers (ARBs).
Tenders are invited for Systemic Antibacterial Use; Blood Substitutes and Perfusion Solutions; Analgesics; Counter Medications Functional Gastrointestinal Disorders; Drugs Used in Cardiology; Renin-Angiotensin System Drugs
Fetal Toxicity: Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.
We're talking about incremental inhibition of the renin-angiotensin system.